MX2017011169A - Uso de citrato ferrico en el tratamiento de anemia por deficiencia de hierro. - Google Patents
Uso de citrato ferrico en el tratamiento de anemia por deficiencia de hierro.Info
- Publication number
- MX2017011169A MX2017011169A MX2017011169A MX2017011169A MX2017011169A MX 2017011169 A MX2017011169 A MX 2017011169A MX 2017011169 A MX2017011169 A MX 2017011169A MX 2017011169 A MX2017011169 A MX 2017011169A MX 2017011169 A MX2017011169 A MX 2017011169A
- Authority
- MX
- Mexico
- Prior art keywords
- iron
- deficiency anemia
- patients
- ferric citrate
- colitis
- Prior art date
Links
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 title abstract 6
- 229960002413 ferric citrate Drugs 0.000 title abstract 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 title abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- 206010009887 colitis Diseases 0.000 abstract 2
- 229910052742 iron Inorganic materials 0.000 abstract 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 2
- 206010056979 Colitis microscopic Diseases 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000035606 childbirth Effects 0.000 abstract 1
- 208000008609 collagenous colitis Diseases 0.000 abstract 1
- 235000018823 dietary intake Nutrition 0.000 abstract 1
- 208000010643 digestive system disease Diseases 0.000 abstract 1
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000004341 lymphocytic colitis Diseases 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000008275 microscopic colitis Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562127963P | 2015-03-04 | 2015-03-04 | |
| PCT/US2016/020575 WO2016141124A1 (en) | 2015-03-04 | 2016-03-03 | Use of ferric citrate in the treatment of iron-deficiency anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017011169A true MX2017011169A (es) | 2017-11-09 |
Family
ID=56848619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017011169A MX2017011169A (es) | 2015-03-04 | 2016-03-03 | Uso de citrato ferrico en el tratamiento de anemia por deficiencia de hierro. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180071243A1 (enExample) |
| EP (1) | EP3265077A4 (enExample) |
| JP (2) | JP2018507260A (enExample) |
| KR (1) | KR20170123664A (enExample) |
| CN (1) | CN107530310A (enExample) |
| AU (1) | AU2016226250B2 (enExample) |
| BR (1) | BR112017018963A2 (enExample) |
| CA (1) | CA2978073A1 (enExample) |
| EA (1) | EA201791960A1 (enExample) |
| HK (2) | HK1246649A1 (enExample) |
| IL (1) | IL254125A0 (enExample) |
| MX (1) | MX2017011169A (enExample) |
| SG (1) | SG11201707120PA (enExample) |
| TW (2) | TW202302083A (enExample) |
| WO (1) | WO2016141124A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102573807A (zh) | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
| JP7387435B2 (ja) * | 2017-09-19 | 2023-11-28 | 日本たばこ産業株式会社 | 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用 |
| FR3075601A1 (fr) * | 2017-12-21 | 2019-06-28 | Clarisse Le Court | Complements alimentaires et leur utilisation sur les menstruations |
| WO2020247935A1 (en) * | 2019-06-07 | 2020-12-10 | Arizona Board Of Regents On Behalf Of Arizona State University | Body fluid iron level panel analyzer |
| WO2022251563A1 (en) | 2021-05-27 | 2022-12-01 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
| WO2023047424A1 (en) * | 2022-04-29 | 2023-03-30 | West Bengal Chemical Industries Limited | Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof |
| KR102623739B1 (ko) * | 2022-07-28 | 2024-01-11 | 주식회사 페라메드 | 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8093423B2 (en) * | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| TWI335218B (en) * | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| WO2005067970A1 (ja) * | 2004-01-14 | 2005-07-28 | Gekkeikan Sake Co., Ltd. | 鉄補給剤及びその利用 |
| JP4931352B2 (ja) * | 2004-01-14 | 2012-05-16 | 月桂冠株式会社 | 鉄補給剤及びその利用 |
| JP5667343B2 (ja) * | 2005-08-18 | 2015-02-12 | パニオン アンド ビーエフ バイオテック インコーポレーテッド | 医薬グレードの第二鉄有機化合物、その使用およびその製造方法 |
| US20120288531A1 (en) * | 2011-01-14 | 2012-11-15 | Shmuel Tuvia | pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
| EA201590062A1 (ru) * | 2012-06-21 | 2016-02-29 | Керикс Байофармасьютикалз, Инк. | Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью |
-
2016
- 2016-03-03 CA CA2978073A patent/CA2978073A1/en not_active Abandoned
- 2016-03-03 TW TW111133966A patent/TW202302083A/zh unknown
- 2016-03-03 WO PCT/US2016/020575 patent/WO2016141124A1/en not_active Ceased
- 2016-03-03 CN CN201680025431.0A patent/CN107530310A/zh active Pending
- 2016-03-03 KR KR1020177027533A patent/KR20170123664A/ko not_active Ceased
- 2016-03-03 EP EP16759457.1A patent/EP3265077A4/en not_active Ceased
- 2016-03-03 SG SG11201707120PA patent/SG11201707120PA/en unknown
- 2016-03-03 BR BR112017018963A patent/BR112017018963A2/pt not_active Application Discontinuation
- 2016-03-03 MX MX2017011169A patent/MX2017011169A/es unknown
- 2016-03-03 EA EA201791960A patent/EA201791960A1/ru unknown
- 2016-03-03 AU AU2016226250A patent/AU2016226250B2/en not_active Expired - Fee Related
- 2016-03-03 HK HK18106104.0A patent/HK1246649A1/zh unknown
- 2016-03-03 HK HK18108472.0A patent/HK1248589A1/zh unknown
- 2016-03-03 US US15/553,348 patent/US20180071243A1/en not_active Abandoned
- 2016-03-03 JP JP2017564757A patent/JP2018507260A/ja active Pending
- 2016-03-03 TW TW105106564A patent/TWI812580B/zh active
-
2017
- 2017-08-23 IL IL254125A patent/IL254125A0/en unknown
-
2021
- 2021-01-26 JP JP2021010151A patent/JP2021091686A/ja active Pending
-
2022
- 2022-12-21 US US18/069,555 patent/US20240075006A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL254125A0 (en) | 2017-10-31 |
| CN107530310A (zh) | 2018-01-02 |
| JP2018507260A (ja) | 2018-03-15 |
| KR20170123664A (ko) | 2017-11-08 |
| US20240075006A1 (en) | 2024-03-07 |
| HK1246649A1 (zh) | 2018-09-14 |
| US20180071243A1 (en) | 2018-03-15 |
| AU2016226250A1 (en) | 2017-09-28 |
| TWI812580B (zh) | 2023-08-21 |
| WO2016141124A1 (en) | 2016-09-09 |
| SG11201707120PA (en) | 2017-09-28 |
| AU2016226250B2 (en) | 2021-05-27 |
| EA201791960A1 (ru) | 2018-01-31 |
| TW202302083A (zh) | 2023-01-16 |
| EP3265077A1 (en) | 2018-01-10 |
| BR112017018963A2 (pt) | 2018-05-15 |
| EP3265077A4 (en) | 2018-10-24 |
| TW201639558A (zh) | 2016-11-16 |
| HK1248589A1 (zh) | 2018-10-19 |
| CA2978073A1 (en) | 2016-09-09 |
| JP2021091686A (ja) | 2021-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017011169A (es) | Uso de citrato ferrico en el tratamiento de anemia por deficiencia de hierro. | |
| MX2019005435A (es) | Composicion farmaceutica, metodos para tratamiento y sus usos. | |
| EA201500996A1 (ru) | Терапевтические применения эмпаглифлозина | |
| JO3709B1 (ar) | تركيبة صيدلانية أو مجموعة طبية للاستخدام في علاج سرطان لدى كائن ثديي تتضمن إنزيم الأسباراجيناز وإنزيم الميثيونيناز | |
| TR201909355T4 (tr) | Oral uygulama için proton bağlayıcı polimerler. | |
| MX2020011099A (es) | Compuestos, composiciones farmaceuticas y metodos de uso de agonistas de ppar. | |
| PH12020550462A1 (en) | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | |
| BR112014001170A2 (pt) | cateter, especialmente um cateter permanente, para tratamento de problemas funcionais e/ou doenças da bexiga e/ou próstata | |
| MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
| WO2015148389A3 (en) | Diagnosis of multiple sclerosis in human and animal subjects | |
| MX2025003477A (es) | Uso de reboxetina para el tratamiento de narcolepsia | |
| EA202191165A1 (ru) | Элацестрант в комбинации с абемациклибом у женщин с раком молочной железы | |
| MX2017017136A (es) | Composicion para el tratamiento de la nafld. | |
| MX2019013683A (es) | Una combinacion farmaceutica para el tratamiento de un cancer. | |
| EA201891922A1 (ru) | Лекарственное средство для лечения инфекций на фоне диабетической стопы | |
| Au | Subcutaneous nodular sarcoidosis: case report | |
| Demchuk et al. | TREATMENT OF PATIENTS WITH CHRONIC DISEASE KIDNEYS OF THE PRESENCE OF LESIONS GASTRODUODENAL AREAS AND CHRONIC PYLONEPHRITIS IN COMBINATION WITH METABOLIC SYNDROME | |
| RU2012158011A (ru) | Метод и композиция для лечения рака | |
| Jong | Curative effect of Beifushu and Aikexin in treating residual burn wounds | |
| Saito | Skin rash: case report | |
| MX2019009337A (es) | Eficacia a largo plazo de tratamiento de enfermedad hepatica con epa y dha. | |
| Xu | EFFECTS OF AURICULAR ACUPRESSURE AND MOXIBUSTION ON THE SYMPTOMS OF WOMEN IN MENOPAUSE | |
| 이상헌 et al. | Endoscopic Resection for Rectal Carcinoid Tumors: Comparision of Polypectomy and Endoscopic Submucosal Resection with Band Ligation | |
| McCarthy | Erythropoietin stimulating agents do not significantly improve quality of life in chronic kidney disease, study finds | |
| RU2009105344A (ru) | Способ лечения поствоспалительных хориоретинальных дистрофий |